Noncanonical effects of vasopressin in angiogenesis

Noncanonical effects of vasopressin in angiogenesis

The molecular action of vasopressin depends on the localization of hormonal receptors. The basic physiological effects of vasopressin are manifested in the blood vasculature, renal inner medulla and brain. To date, new information concerning the tissue-specific spreading of vasopressin receptors has...

Full description

Bibliographic Details
Main Author:	I. I. Khegay
Format:	Article
Language:	English
Published:	Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders 2019-08-01
Series:	Вавиловский журнал генетики и селекции
Subjects:	vasopressin v1aand v2-receptors platelet endotheliocyte hyaluronic acid hyaluronidase hyal2 protein pecam-1–integrin αvβ3
Online Access:	https://vavilov.elpub.ru/jour/article/view/2208

Similar Items

Metabolic effects of vasopressin in pathophysiology of diabetic kidney disease
by: Svetlana Lebedeva, et al.
Published: (2023-09-01)

Effect of vasopressin on the expression of genes for key enzymes of interstitial hyaluronan turnover and concentration ability in WAG rat kidneys
by: L. N. Ivanova, et al.
Published: (2016-05-01)

Effect of vasopressin V2-receptor antagonist tolvaptan on syndrome of inappropriate antidiuresis (SIAD) after transsphenoidal pituitary surgery: recovery of measured osmolality
by: Masahiko Tosaka, et al.
Published: (2022-10-01)

Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells
by: Annarita Di Mise, et al.
Published: (2019-12-01)

Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer
by: Krishan Kumar, et al.
Published: (2023-05-01)

Search for antiviral functions of potentially protective antibodies against V2 region of HIV-1
by: Miroslaw K. Gorny
Published: (2020-09-01)

Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
by: Andrea Balduit, et al.
Published: (2023-06-01)

Inhibition of hyaluronic acid degradation pathway suppresses glioma progression by inducing apoptosis and cell cycle arrest
by: Tao Yan, et al.
Published: (2023-08-01)

Utility of Platelet Endothelial Cell Adhesion Molecule 1 in the Platelet Activity Assessment in Mouse and Human Blood
by: Natalia Marcinczyk, et al.
Published: (2021-09-01)

Hyaluronidase 6 Does Not Affect Cumulus–Oocyte Complex Dispersal and Male Mice Fertility
by: Hyewon Bang, et al.
Published: (2022-04-01)

V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology
by: László Sándor Erdélyi, et al.
Published: (2023-05-01)

Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
by: Mladena Glavaš, et al.
Published: (2022-03-01)

Ethanolic Extract of <i>Ocimum sanctum</i> Linn. Inhibits Cell Migration of Human Lung Adenocarcinoma Cells (A549) by Downregulation of Integrin αvβ3, α5β1, and VEGF
by: Ulayatul Kustiati, et al.
Published: (2022-10-01)

The Vasopressin Receptor 2 Mutant R137L Linked to the Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) Signals through an Alternative Pathway that Increases AQP2 Membrane Targeting Independently of S256 Phosphorylation
by: Marianna Ranieri, et al.
Published: (2020-05-01)

The Ways of the Virus: Interactions of Platelets and Red Blood Cells with SARS-CoV-2, and Their Potential Pathophysiological Significance in COVID-19
by: Mikhail A. Panteleev, et al.
Published: (2023-12-01)

Exploring the Role of RGD-Recognizing Integrins in Cancer
by: Markus Nieberler, et al.
Published: (2017-09-01)

Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells
by: Aditi Gupta, et al.
Published: (2013-05-01)

Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment
by: Nicholas F. Brown, et al.
Published: (2019-08-01)

Comparison of natural and artificial vasopressin deficiency: why the latter is lethal?
by: D. Zelena
Published: (2016-05-01)

Pathophysiology of Drug-Induced Hyponatremia
by: Gheun-Ho Kim
Published: (2022-09-01)

Targeting integrin αvβ3 with indomethacin inhibits patient‐derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma
by: Fangfang Liu, et al.
Published: (2021-10-01)

CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity
by: Myo-Hyeon Park, et al.
Published: (2019-08-01)

Synthesis and Systematic Study on the Effect of Different PEG Units on Stability of PEGylated, Integrin-αvβ6-Specific A20FMDV2 Analogues in Rat Serum and Human Plasma
by: Kuo-yuan Hung, et al.
Published: (2022-07-01)

PECAM-1/Thrombus Ratio Correlates with Blood Loss during Off-Pump Coronary Artery Bypass Grafting (OPCAB) Surgery: A Preliminary Study
by: Natalia Bielicka, et al.
Published: (2023-08-01)

The scaffold of neutrophil extracellular traps promotes CCA progression and modulates angiogenesis via ITGAV/NFκB
by: Congyi Zhang, et al.
Published: (2024-02-01)

Comparative Assessment of the Inhibitory Potential of the Herbicide Glyphosate and Its Structural Analogs on RGD-Specific Integrins Using Enzyme-Linked Immunosorbent Assays
by: Borbála Gémes, et al.
Published: (2022-10-01)

Proteomic studies of VEGFR2 in human placentas reveal protein associations with preeclampsia, diabetes, gravidity, and labor
by: Shannon J. Ho, et al.
Published: (2024-04-01)

Platelet-derived microparticles adoptively transfer integrin β3 to promote antitumor effect of tumor-infiltrating T cells
by: Mimi Zhou, et al.
Published: (2024-12-01)

Posttranslational modifications of platelet adhesion receptors
by: Shukun Sun, et al.
Published: (2022-09-01)

The origins of major platelet receptor nomenclature
by: Kenneth J. Clemetson
Published: (2017-01-01)

Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy
by: David M. Davies, et al.
Published: (2024-03-01)

The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials
by: Yanlun Gu, et al.
Published: (2023-03-01)

Integrin αvβ3 in the Mediating Effects of Dihydrotestosterone and Resveratrol on Breast Cancer Cell Proliferation
by: Yih Ho, et al.
Published: (2020-04-01)

Dual integrin αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging
by: Yin Song, et al.
Published: (2018-11-01)

β-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor
by: Carole Daly, et al.
Published: (2023-10-01)

Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment
by: Ewa Brzozowska, et al.
Published: (2022-10-01)

Integrins and Actions of Androgen in Breast Cancer
by: Chung-Che Tsai, et al.
Published: (2023-08-01)

M2‐like macrophage‐derived exosomes facilitate metastasis in non‐small‐cell lung cancer by delivering integrin αVβ3
by: Lamei Huang, et al.
Published: (2023-02-01)

Molecular Cross-Talk between Integrins and Cadherins Leads to a Loss of Vascular Barrier Integrity during SARS-CoV-2 Infection
by: Danielle Nader, et al.
Published: (2022-04-01)

Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy
by: Mark Sutherland, et al.
Published: (2023-08-01)